Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial
Authors:
Kong T, Mabry A, Highkin M, [...]one or more additional authors omittedOpyrchal M, [...]one or more additional authors omitted Ma CX
